Abstract:Background: As the most commonly used illicit substance, cannabis is gaining global acceptance through increasing legalization efforts. This shift intensifies the need for research to guide policymakers and healthcare providers in harm reduction and treatment strategies. Nonetheless, the relationship between psychopathological symptoms and cannabis use remains inadequately understood. Methods: A sample of regular cannabis consumers completed self-reported assessments for depression (Patient Health Questionnaire-9), anxiety (General Anxiety Disorder-7), Attention-Deficit/Hyperactivity Disorder (ADHD; Adult ADHD Self-Report Scale V1.1), and psychosis (Early Recognition Inventory based on IRAOS) as well as previous black-market cannabis use patterns. Cannabis Use Disorder Identification Test Revised (CUDIT-R) was used to identify cannabis use disorder (CUD). To understand psychopathological symptom load related to cannabis consumption as well as cannabis use motives, multiple regression models were performed to identify psychopathological variables predicting cannabis use frequency and quantity. Linear regression and correlation analyses were conducted, adjusting for relevant covariates (age, gender, education, alcohol, other substance use). Results: Three-hundred-sixty regular cannabis users interested in a study on regulated cannabis access in Basel, Switzerland were examined. In bivariate analysis, cannabis use frequency correlated with depressive (r(358) = 0.16, p = 0.003) and anxiety symptom load (r(358) = 0.11, p = 0.034). Cannabis quantity correlated with depressive (r(358) = 0.15, p = 0.005), ADHD (r(358) = 0.14, p = 0.008), and psychosis symptom load (r(358) = 0.16, p = 0.002). However, in the adjusted regression models only depressive and ADHD symptom loads were significantly associated with cannabis use frequency (p = 0.006 and p = 0.034, respectively) and quantity (p = 0.037 and p = 0.019, respectively). No significant correlations between cannabis consumption and anxiety or psychosis remained after adjustment. Conclusion: ADHD and depressive symptoms correlate with increased cannabis use in a cohort of regular users, suggesting potential self-medication in nonclinical populations. With the rising availability of cannabis worldwide, these results highlight the necessity for longitudinal studies to disentangle the complex dynamics between cannabis consumption and mental health symptoms.

Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence from the Population-Based World Health Organization World Mental Health Survey Initiative.

Cannabis use during adolescence and the occurrence of depression, suicidality and anxiety disorder across adulthood: Findings from a longitudinal cohort study over 30 years

Trends of major depressive episode among people with cannabis use: Findings from the National Survey on Drug Use and Health 2006–2015

The longitudinal association of cumulative depression with cannabis use disorder among young adults

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls

Cannabis Use at A Young Age is Associated with Psychotic Experiences

Cannabis Use is a Better Indicator of Poor Mental Health in Women Than in Men: a Cross-Sectional Study in Young Adults from the General Population.

Cannabis Use As An Indicator Of Risk For Mental Health Problems In Adolescents: A Population-Based Study At Secondary Schools

Age-dependent association of cannabis use with risk of psychotic disorder

Cannabis Use and Subclinical Positive Psychotic Experiences in Early Adolescence: Findings from a Dutch Survey.

Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis

INITIAL AGE AND AMOUNT OF CANNABIS EXPOSURE ARE STRONGLY ASSOCIATED WITH PSYCHOSIS VULNERABILITY IN A SAMPLE OF 18,000 DUTCH ADOLESCENTS

Cannabis use and suicide attempts among 86,254 adolescents aged 12-15 years from 21 low- and middle-income countries.

Cannabis use in adolescents and anxiety symptoms and disorders: a systematic review and meta-analysis

Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys.

Cannabis use, depression and self-harm: phenotypic and genetic relationships

Depressive symptoms predict cannabis vaping initiation among young adults

Cannabis use and sleep problems among young adults by mental health status: A prospective cohort study

Association between cannabis and psychiatric hospitalization.

Association of cannabis use with depression among cancer patients

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability